Atlanta, Georgia, Jan 26, 2026  –  today officially announced that a strategic acquisition was finalized earlier this year, bringing in new ownership with a distinct, concentrated pledge to enhancing quality, regulatory compliance, and scientific integrity throughout all facets of the organization.

Through this shift, Ponya Therapeutics is reaffirming its mission to propel the regenerative medicine sector forward by supplying premium tissue allografts that meet regulatory benchmarks and address the developing requirements of healthcare practitioners across the nation. The incoming leadership group introduces a quality-priority philosophy grounded in operational distinction, stringent supervision, and an extended-range perspective for conscientious advancement in regenerative medicine.

Our objective is straightforward yet compelling. We aim to guarantee that physicians have availability to tissue allograft products processed according to the supreme benchmarks of attention, security, and conformity – enabling them to render knowledgeable determinations for their patients.

Expanding Access Through Awareness

As a component of its development approach, Ponya Therapeutics is commencing a nationwide outreach program to contact 1,000 new medical clinics to appraise the merits of partnering with Ponya Therapeutics via our cash products. This undertaking concentrates on instruction, visibility, and accessibility – propelled by the principle that patients throughout America ought to possess regenerative alternatives accessible via qualified medical providers.

By amplifying visibility and product availability, Ponya Therapeutics intends to aid physicians in investigating compliant regenerative remedies while assisting in broadening accountable accessibility across the United States.

We believe merits inclusion in discussions regarding contemporary healthcare. This program concerns learning, assessment, and selection – for both suppliers and recipients.

With the new ownership established and a revitalized dedication to superiority, Ponya Therapeutics is situating itself for deliberate growth – directed by adherence, clarity, and scientific accountability. The corporation persists in its commitment to assisting physicians while adding to the wider recognition and accessibility of regenerative alternatives in the U.S.

For further details about Ponya Therapeutics, browse to .

About Ponya Therapeutics
constitutes a regenerative medicine enterprise concentrating on supplying to medical practitioners. The organization is devoted to innovation, protection, and scientific authenticity, possessing a mission to advocate compliant regenerative selections for patients countrywide.